Personalised Post-operative monitoring and fluid therapy vs standard of care in recipients of Living donor kidney transplant

Not Applicable

• Conditions: Kidney failure; Kidney Transplantation; Renal and Urogenital - Kidney disease; Surgery - Other surgery; Public Health - Health service research

• Registration Number: ACTRN12622001093774
• Lead Sponsor: Kidney, Transplant and Diabetes Research Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-08
• Last Update Posted: 6 February 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Adult (18 years of age or older) patients undergoing living donor kidney transplantation, who are able to provide written consent.

Exclusion Criteria

Patient requiring peri-operative plasma exchange for either high Angiotensin II Receptor Type 1 antibodies or pre-formed Human Leukocyte Antigen (HLA) antibodies. These patients may require post operative plasma exchange, which may not be able to be delivered in a timely fashion to the intervention arm with current levels of resourcing.

Study & Design

• Study Type: Interventional
• Study Design: Not specified